Chemoinformaics analysis of 22-HYDROXYTETRATRIACONTAN-13-ONE
| Molecular Weight | 508.916 | nRot | 31 |
| Heavy Atom Molecular Weight | 440.372 | nRig | 2 |
| Exact Molecular Weight | 508.522 | nRing | 0 |
| Solubility: LogS | -1.365 | nHRing | 0 |
| Solubility: LogP | 1.886 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 104 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 68 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 103.726 |
| nHD | 1 | BPOL | 69.0861 |
| QED | 0.53 |
| Synth | 3.609 |
| Natural Product Likeliness | 0.797 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.266 |
| MDCK | 0.0000243 |
| BBB | 0.998 |
| PPB | 0.823457 |
| VDSS | 0.881 |
| FU | 0.300864 |
| CYP1A2-inh | 0.32 |
| CYP1A2-sub | 0.601 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.802 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.247 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.348 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.279 |
| CL | 11.278 |
| T12 | 0.874 |
| hERG | 0.005 |
| Ames | 0.107 |
| ROA | 0.05 |
| SkinSen | 0.073 |
| Carcinogencity | 0.043 |
| EI | 0.964 |
| Respiratory | 0.142 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.581081 |